Pioglitazone enhances cisplatin's impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
Peroxisome proliferator-activated receptor-gamma (PPARγ) has been recently shown to play a role in many cancers. The breast tissue of triple-negative breast cancer (TNBC) patients were found to have a significantly lower expression of PPARγ than the other subtypes. Furthermore, PPARγ activation was...
Saved in:
Main Authors: | Qamraa Hamad Alqahtani (Author), Layla Abdullah Alkharashi (Author), Hanaa Alajami (Author), Ishraq Alkharashi (Author), Layan Alkharashi (Author), Shoug Nasser Alhinti (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pioglitazone, a PPAR-γ Activator, Stimulates BKCa but Suppresses IKM in Hippocampal Neurons
by: Tsang-Shan Chen, et al.
Published: (2018) -
PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling
by: Nasim Dana, et al.
Published: (2019) -
Prophylactic and Ameliorative Effects of PPAR-γ Agonist Pioglitazone in Improving Oxidative Stress, Germ Cell Apoptosis and Inflammation in Gentamycin-Induced Testicular Damage in Adult Male Albino Rats
by: Karima El-Sayed, et al.
Published: (2022) -
Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines
by: Randa Mohammed Zaki, et al.
Published: (2023) -
Anticoagulation Control of Warfarin in Pharmacist-Led Clinics Versus Physician-Led Clinics: A Prospective Observational Study
by: Alghadeeer S, et al.
Published: (2020)